The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany.
Theo DähneWolfgang BauerAndreas EssigBernhard SchaafChristoph D SpinnerMathias W PletzGernot G U RohdeJan RuppMartin WitzenrathMarcus Panningnull nullPublished in: Emerging microbes & infections (2021)
We show a shift in the prevalence of respiratory viral pathogens in community-acquired pneumonia patients during the COVID-19 pandemic. Our data support the efficiency of non-pharmaceutical interventions on virus circulation except for rhinoviruses. The consequences of an altered circulation on subsequent winter seasons remain unclear and support the importance of systematic virological surveillance.
Keyphrases
- community acquired pneumonia
- sars cov
- respiratory tract
- end stage renal disease
- risk factors
- chronic kidney disease
- ejection fraction
- respiratory syndrome coronavirus
- newly diagnosed
- public health
- gram negative
- coronavirus disease
- physical activity
- peritoneal dialysis
- antimicrobial resistance
- electronic health record
- multidrug resistant
- patient reported outcomes
- big data
- artificial intelligence